Capillary Tech. Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹271 Cr +51.4% YoYSee revenue, profit and what management said. You are viewing Q1 FY27.
CT

Capillary Tech.

Q1 FY27IT - Software

Capillary Technologies India Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Revenue
₹257Cr
+42.8% YoY
+34.6% QoQ
Net profit
−₹10Cr
Q1 FY26: ₹1 Cr
Margin
16%
+6 pp YoY
0 pp QoQ

What the Q1 FY27 call signalled

2 of 3 strong

RevenueGood growth
MarginMargins steady
CapexCapex planned
Price₹510
Market cap₹4.0K Cr
P/E78.0

The short version

Capillary Technologies expects to exceed their revenue guidance of INR1,065 crores and INR172 crores EBITDA. Capillary Technologies expects to exceed its revenue guidance of INR1,065 crores and INR172 crores EBITDA.

From Capillary Tech.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Good growth
  • Capillary Technologies expects to exceed their revenue guidance of INR1,065 crores and INR172 crores EBITDA.
  • New Annual Contract Value (ACV) grew about 75% YoY, indicating strong momentum in new sales across US, Europe, and Asia.
  • Organic growth guidance for FY27 is around 17%-23%, with inorganic growth supplementing this.
  • SessionM acquisition adds to revenue with server cost efficiencies improving margins; migration expected over 2-3 years.
  • Net Retention Rate (NRR) expansion and upselling new AI products contribute to higher revenues and margins.
  • Company targets combined 15%-20% organic growth with ongoing inorganic acquisitions as a sales motion.

2 more points from Capillary Tech.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Capillary Tech. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
Some relevant points inferred include: - Focus on M&A strategy: The company continues to pursue inorganic growth by acquiring businesses, primarily to add long-term contracts and migrate customers to Capillary’s tech platform. - Investments in technology: Significant investment in AI for faster and more efficient migration of acquired customers to Capillary’s platform. - Product and platform enhancements: Continuous investment to maintain a leadership position and stay at least a year ahead of competitors in product quality.

Top-ranked in IT - Software

Ranked on what management guided this quarter

Guidance-ranked
1Workmates Core2
Rev 1Mar 1
2Virtual Galaxy
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Capillary Tech. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The ACV (Annual Contract Value) reported was INR 92 crores, up from INR 53 crores previously, representing about 80% growth on a trailing 12-month basis.
  • Average deal cycles are approximately 9 months, so quarter-to-quarter comparisons are less meaningful.
  • There is strong momentum in new sales across the US, Europe, and Asia.
  • Expecting at least 30%-40% more new ACV than last year, though unlikely to hit 75% growth for the full year.

2 more points from Capillary Tech.'s call on order book

Create a free account to keep reading this call

Capillary Tech. — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Capillary Tech. Q1 FY27 results — key figures

Capillary Tech. Q1 FY27 reported results vs Q1 FY26, ₹ crore
₹ CrQ1 FY27Q1 FY26YoYQ4 FY26QoQ
Revenue257180+42.8%191+34.6%
Operating profit (EBITDA)4018+122.2%31+29%
Operating margin16%10%+6 pp16%0 pp
Profit before tax-91-1000%42-121.4%
Net profit (PAT)-101-1100%43-123.3%
EPS (₹)-1.200.10-1300%5.46-122%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹271 Cr, net profit ₹22 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Capillary Technologies India's management said in earlier quarters

Others in IT - Software this season

  • Delaplex (Q1 FY27)

    H2 FY26 total income (quarterly equivalent): ₹340.4 Mn vs ₹328.4 Mn in H2 FY25, a 3.66% YoY increase. Key investor presentation takeaways from Delaplex Ltd's Q1

  • Xelpmoc Design (Q1 FY27)

    Q1 FY27 Revenue from Operations: Rs 9.6 million, up 22.5% YoY from Rs 7.8 million in Q1 FY26 (Page 27). Key investor presentation takeaways from Xelpmoc Design'

  • Cybertech Systems & Software (Q1 FY27)

    Total Revenue: ₹766.3 million, up 17.5% YoY (Page 3, 15, 19) . Key investor presentation takeaways from Cybertech Systems & Software Ltd's Q1 FY27 investor pres

  • Workmates Core2 (Q1 FY27)

    FY26 total revenue: ₹143 Cr (Page 10) . Key concall takeaways from Workmates Core2cloud Solution Ltd's Q1 FY27 earnings call — and how it ranks against sector…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Capillary Tech. and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Capillary Tech. Q1 FY27 results?

Capillary Technologies expects to exceed their revenue guidance of INR1,065 crores and INR172 crores EBITDA. Capillary Technologies expects to exceed its revenue guidance of INR1,065 crores and INR172 crores EBITDA.

What is Capillary Tech. share price analysis?

Capillary Tech. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 78.0 with a market cap of ₹3,998 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Capillary Tech. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.